Gastroenterologists' attitudes on the detection and management of gastric premalignant conditions: results of a nationwide survey in Spain.
Journal
European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)
ISSN: 1473-5709
Titre abrégé: Eur J Cancer Prev
Pays: England
ID NLM: 9300837
Informations de publication
Date de publication:
01 11 2021
01 11 2021
Historique:
pubmed:
29
12
2020
medline:
20
4
2022
entrez:
28
12
2020
Statut:
ppublish
Résumé
Gastric premalignant conditions (GPC) surveillance has been proposed to improve the prognosis of gastric cancer (GC), but the early GC detection rate remaining low, and missing GC during an esophago-gastro-duodenoscopy is still a problem. We aimed to explore the gastroenterologists' attitudes on the detection and management of GPC. A cross-sectional study was designed based on a survey among gastroenterologists from Asociación Española de Gastroenterología. The participation rate was 12% (146/1243). Eighty-one percent worked at secondary or tertiary-care hospitals with the capability to perform mucosectomy (80%), but with a lesser availability of endoscopic submucosal dissection (35%). Most respondents had high-definition endoscopes (88%), and virtual chromoendoscopy (86%), but during performing an upper endoscopy, 34% never or rarely use chromoendoscopy, and 73% apply a biopsy protocol often/very often when atrophy or intestinal metaplasia (IM) is suspected. Half of the respondents self-reported their ability to recognize atrophy or IM ≤7 (on a scale from 0 to 10), whereas ≤6 for dysplasia or early GC. Helicobacter pylori infection is eradicated and verified by ≥90%. Endoscopic surveillance of atrophy/IM is performed by 62%. An immediate endoscopy for dysplasia is not always performed. For low-grade dysplasia, 97.6% consider endoscopic management, but for high-grade dysplasia, 23% regard gastric surgery. There is a wide variability in the detection and management of GPC among Spanish gastroenterologists, and compliance with guidelines and biopsy protocols could be improved. Performance of high-quality gastroscopies including use of virtual chromoendoscopy, that might allow an improvement in the GPC detection, needs also to be generalized.
Identifiants
pubmed: 33369947
doi: 10.1097/CEJ.0000000000000648
pii: 00008469-202111000-00002
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
431-436Informations de copyright
Copyright © 2020 Wolters Kluwer Health, Inc. All rights reserved.
Références
Alcaraz Serrat JA, Córdova H, Moreira L, Pocurrull A, Ureña R, Delgado-Guillena PG, et al. (2020). Evaluation of long-term adherence to oesophagogastroduodenoscopy quality indicators. Gastroenterol Hepatol 43:589–597.
Banks M, Graham D, Jansen M, Gotoda T, Coda S, di Pietro M, et al. (2019). British Society of Gastroenterology guidelines on the diagnosis and management of patients at risk of gastric adenocarcinoma. Gut 68:1545–1575.
Beg S, Ragunath K, Wyman A, Banks M, Trudgill N, Pritchard DM, et al. (2017). Quality standards in upper gastrointestinal endoscopy: a position statement of the British Society of Gastroenterology (BSG) and Association of Upper Gastrointestinal Surgeons of Great Britain and Ireland (AUGIS). Gut 66:1886–1899.
Bisschops R, Areia M, Coron E, Dobru D, Kaskas B, Kuvaev R, et al. (2016). Performance measures for upper gastrointestinal endoscopy: a European Society of Gastrointestinal Endoscopy quality improvement initiative. United European Gastroenterol J 4:629–656.
Chapelle N, Bouvier AM, Manfredi S, Drouillard A, Lepage C, Faivre J, Jooste V (2016). Early gastric cancer: trends in incidence, management, and survival in a well-defined French population. Ann Surg Oncol 23:3677–3683.
Chapelle N, Péron M, Mosnier JF, Quénéhervé L, Coron E, Bourget A, et al. (2020). Prevalence, characteristics and endoscopic management of gastric premalignant lesions in France. Dig Dis 38:286–292.
Chen HN, Wang Z, Li X, Zhou ZG (2016). Helicobacter pylori eradication cannot reduce the risk of gastric cancer in patients with intestinal metaplasia and dysplasia: evidence from a meta-analysis. Gastric Cancer 19:166–175.
Córdova H, Sánchez-Montes C, Delgado-Guillena PG, Morales VJ, Sendino O, González-Suárez B, et al. (2017). Quality indicators for esophagogastroduodenoscopy: a comparative study of outcomes after an improvement programme in a tertiary hospital. Gastroenterol Hepatol 40:587–594.
Correa P (2013). Gastric cancer: overview. Gastroenterol Clin North Am 42:211–217.
De Angelis R, Sant M, Coleman MP, Francisci S, Baili P, Pierannunzio D, et al.; EUROCARE-5 Working Group. (2014). Cancer survival in Europe 1999-2007 by country and age: results of EUROCARE–5-a population-based study. Lancet Oncol 15:23–34.
Delgado-Guillena P, Morales-Alvarado J, Ramirez-Salazar C, Jimeno-Ramiro M, Llibre-Nieto G, Galvez-Olortegui J, et al. (2020). Frequency and clinical characteristics of early gastric cancer in comparison to advanced gastric cancer in a health area of Spain. Gastroenterol Hepatol 43:506–514.
Delgado Guillena PG, Morales Alvarado VJ, Jimeno Ramiro M, Rigau Cañardo J, Ramírez Salazar C, García Rodríguez A, et al. (2019). Gastric cancer missed at esophagogastroduodenoscopy in a well-defined Spanish population. Dig Liver Dis 51:1123–1129.
Dixon MF, Genta RM, Yardley JH, Correa P (1996). Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 20:1161–1181.
Gisbert JP, Calvet X, Ferrándiz J, Mascort J, Alonso-Coello P, Marzo M; Sociedad Española de Medicina de Familia y Comunitaria. (2012). [Clinical practice guideline on the management of patients with dyspepsia. Update 2012]. Gastroenterol Hepatol 35:725.e1–725.38.
Gotoda T, Uedo N, Yoshinaga S, Tanuma T, Morita Y, Doyama H, et al. (2016). Basic principles and practice of gastric cancer screening using high-definition white-light gastroscopy: eyes can only see what the brain knows. Dig Endosc 28 (Suppl 1):2–15.
Gupta S, Li D, El Serag HB, Davitkov P, Altayar O, Sultan S, et al. (2020). AGA clinical practice guidelines on management of gastric intestinal metaplasia. Gastroenterology 158:693–702.
Huang RJ, Ende AR, Singla A, Higa JT, Choi AY, Lee AB, et al. (2020). Prevalence, risk factors, and surveillance patterns for gastric intestinal metaplasia among patients undergoing upper endoscopy with biopsy. Gastrointest Endosc 91:70–77.e1.
Khanderia E, Markar SR, Acharya A, Kim Y, Kim YW, Hanna GB (2016). The influence of gastric cancer screening on the stage at diagnosis and survival: a meta-analysis of comparative studies in the far east. J Clin Gastroenterol 50:190–197.
Lahner E, Zagari RM, Zullo A, Di Sabatino A, Meggio A, Cesaro P, et al. (2019). Chronic atrophic gastritis: natural history, diagnosis and therapeutic management. A position paper by the Italian Society of Hospital Gastroenterologists and Digestive Endoscopists [AIGO], the Italian Society of Digestive Endoscopy [SIED], the Italian Society of Gastroenterology [SIGE], and the Italian Society of Internal Medicine [SIMI]. Dig Liver Dis 51:1621–1632.
Malfertheiner P, Megraud F, O’Morain CA, Gisbert JP, Kuipers EJ, Axon AT, et al.; European Helicobacter and Microbiota Study Group and Consensus panel. (2017). Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report. Gut 66:6–30.
McNicholl AG, Amador J, Ricote M, Cañones-Garzón PJ, Gene E, Calvet X, et al. (2019). Spanish primary care survey on the management of Helicobacter pylori infection and dyspepsia: information, attitudes, and decisions. Helicobacter 24:1–10.
Pandey R, Millar A (2011). Management of gastric intestinal metaplasia in the UK: a preliminary survey [abstract]. Gut 60:A105.
Park WG, Shaheen NJ, Cohen J, Pike IM, Adler DG, Inadomi JM, et al. (2015). Quality indicators for EGD. Gastrointest Endosc 81:17–30.
Pimenta-Melo AR, Monteiro-Soares M, Libânio D, Dinis-Ribeiro M (2016). Missing rate for gastric cancer during upper gastrointestinal endoscopy: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol 28:1041–1049.
Pimentel-Nunes P, Libânio D, Marcos-Pinto R, Areia M, Leja M, Esposito G, et al. (2019). Management of epithelial precancerous conditions and lesions in the stomach (MAPS II): European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter and Microbiota Study Group (EHMSG), European Society of Pathology (ESP), and Sociedade Portuguesa de Endoscopia Digestiva (SPED) guideline update 2019. Endoscopy 51:365–388.
Quach DT, Hiyama T, Gotoda T (2019). Identifying high-risk individuals for gastric cancer surveillance from western and eastern perspectives: Lessons to learn and possibility to develop an integrated approach for daily practice. World J Gastroenterol 25:3546–3562.
Sugano K, Tack J, Kuipers EJ, Graham DY, El-Omar EM, Miura S, et al.; faculty members of Kyoto Global Consensus Conference. (2015). Kyoto global consensus report on Helicobacter pylori gastritis. Gut 64:1353–1367.
Tai FWD, Wray N, Sidhu R, Hopper A, McAlindon M (2020). Factors associated with oesophagogastric cancers missed by gastroscopy: a case-control study. Frontline Gastroenterol 11:194–201.
Vance RB Jr, Kubiliun N, Dunbar KB (2016). How do we manage gastric intestinal metaplasia? A survey of clinical practice trends for gastrointestinal endoscopists in the United States. Dig Dis Sci 61:1870–1878.
von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke J. P; STROBE Initiative. (2014). The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. Int J Surg 12:1495–1499.
Yao K (2013). The endoscopic diagnosis of early gastric cancer. Ann Gastroenterol 26:11–22.
Yip HC, Uedo N, Chan SM, Teoh AYB, Wong SKH, Chiu PW, Ng EKW (2020). An international survey on recognition and characterization of atrophic gastritis and intestinal metaplasia. Endosc Int Open 8:E1365–E1370.
Zhang X, Li M, Chen S, Hu J, Guo Q, Liu R, et al. (2018). Endoscopic screening in Asian countries is associated with reduced gastric cancer mortality: a meta-analysis and systematic review. Gastroenterology 155:347–354.e9.